Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA5A | P35218 | 2/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4545352 | 0.87 | KMT2A (0.50) | SMN1; SMN2CXCR3MEN1KMT2ACA1 | |
| SCHEMBL18962226 | 0.87 | KMT2A (0.50) | SMN1; SMN2CXCR3MEN1KMT2ACA1 | |
| SCHEMBL15617809 | 0.86 | CXCR3 (0.41) | SMN1; SMN2CXCR3MEN1KMT2ACA1 | |
| SCHEMBL13829134 | 0.86 | KMT2A (0.40) | SMN1; SMN2CXCR3MEN1KMT2ACA1 | |
| SCHEMBL17231422 | 0.84 | KMT2A (0.44) | SMN1; SMN2CXCR3MEN1KMT2ACA1 | |
| SCHEMBL8968927 | 0.84 | FTO (0.45) | SMN1; SMN2CXCR3MEN1KMT2ACA1 | |
| SCHEMBL24025853 | 0.83 | MEN1 (0.38) | SMN1; SMN2CXCR3MEN1KMT2ACA1 | |
| SCHEMBL13829261 | 0.83 | MEN1 (0.37) | SMN1; SMN2CXCR3MEN1KMT2ACA1 | |
| SCHEMBL25823453 | 0.83 | MEN1 (0.37) | SMN1; SMN2CXCR3MEN1KMT2ACA1 | |
| SCHEMBL13829344 | 0.83 | CXCR3 (0.38) | SMN1; SMN2CXCR3MEN1KMT2ACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079724-A1 | SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2018-03-22 | — | — | US | disclosed |
| US-20180079724-A1 | SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION | ADEKA CORPORATION (JP) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079724-A1 | SULFONIC ACID DERIVATIVE COMPOUND, PHOTOACID GENERATOR, RESIST COMPOSITION, CATIONIC POLYMERIZATION INITIATOR, AND CATIONICALLY POLYMERIZABLE COMPOSITION | ALAD, ADSL, ACSL3 | SMN1; SMN2 4194/4885CXCR3 3633/4885MEN1 4527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.